Published in Melanoma Res on August 01, 1995
Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med (2014) 10.69
Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg (2005) 3.80
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol (2008) 1.67
Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up. World J Surg (2005) 1.47
Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg (2001) 1.36
Influence of fast lymphatic drainage on metastatic spread in cutaneous malignant melanoma: a prospective feasibility study. Eur J Nucl Med Mol Imaging (2003) 1.20
Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg (2001) 1.05
The role of sentinel lymph node biopsy in the management of melanoma. Adv Surg (2007) 0.98
The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status. J Clin Pathol (2005) 0.98
Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg (2004) 0.90
Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma. Br J Dermatol (2013) 0.90
Progression of cutaneous melanoma: implications for treatment. Clin Exp Metastasis (2012) 0.87
Sentinel lymph node biopsy progress in surgical treatment of cancer. Langenbecks Arch Surg (2004) 0.87
Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol (2004) 0.87
Primary cutaneous melanoma of the breast: A case report. Cases J (2008) 0.85
Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer (2009) 0.84
Microenvironment of tumor-draining lymph nodes: opportunities for liposome-based targeted therapy. Int J Mol Sci (2014) 0.84
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging (2015) 0.83
Impact of sentinel lymphadenectomy on survival in a murine model of melanoma. Clin Exp Metastasis (2008) 0.83
Clinical utilities and biological characteristics of melanoma sentinel lymph nodes. World J Clin Oncol (2016) 0.82
Treatment strategy for cutaneous malignant melanoma. Int J Clin Oncol (2005) 0.80
The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma--a retrospective analysis of 392 cases. Br J Cancer (2008) 0.80
Sentinel lymph node biopsy for cutaneous melanoma: results of 10 years' experience in two regional training hospitals in the Netherlands. Int J Clin Oncol (2012) 0.79
Confirmation of sentinel lymph node identity by analysis of fine-needle biopsy samples using inductively coupled plasma-mass spectrometry. Ann Surg Oncol (2008) 0.78
SLN melanoma micrometastasis predictivity of nodal status: a long term retrospective study. J Exp Clin Cancer Res (2013) 0.76
Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2015) 0.75
Primary malignant melanoma of the breast: A case report and review of the literature. Oncol Lett (2014) 0.75
Update and Review on the Surgical Management of Primary Cutaneous Melanoma. Healthcare (Basel) (2014) 0.75
Correlation between theoretical anatomical patterns of lymphatic drainage and lymphoscintigraphy findings during sentinel node detection in head and neck melanomas. Eur J Nucl Med Mol Imaging (2015) 0.75
The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients. Eur J Nucl Med Mol Imaging (2011) 0.75
Sentinel node biopsy versus elective lymph node dissection in patients with cutaneous melanoma in a Japanese population. Int J Clin Oncol (2007) 0.75
Cancer survival in England and Wales at the end of the 20th century. Br J Cancer (2008) 4.18
Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer (2004) 4.06
Aerobic work capacity in patients with chronic fatigue syndrome. BMJ (1990) 2.86
Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology (1988) 2.60
Deprivation, stage at diagnosis and cancer survival. Int J Cancer (1995) 2.50
Current trends in colorectal cancer: site, incidence, mortality and survival in England and Wales. Clin Oncol (R Coll Radiol) (2001) 2.41
Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma unit from 1960 to 1991. J Am Coll Surg (1995) 2.38
Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol (2004) 2.36
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32
Deprivation and survival from breast cancer. Br J Cancer (1995) 2.27
Androgen-induced hepatoma. Lancet (1975) 2.21
Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol (2001) 2.15
Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer (1998) 2.12
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09
Resection margins for melanoma. Aust N Z J Surg (1985) 1.92
Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol (2000) 1.88
Liver disease and common-bile-duct stenosis in cystic fibrosis. N Engl J Med (1988) 1.79
Cancer prevalence in European registry areas. Ann Oncol (2002) 1.72
Myopericytoma: a unifying term for a spectrum of tumours that show overlapping features with myofibroma. A review of 14 cases. J Clin Pathol (2006) 1.72
Lead intake and blood lead in two-year-old U.K. urban children. Sci Total Environ (1990) 1.69
Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg (1999) 1.68
Lead exposure in young children from dust and soil in the United Kingdom. Environ Health Perspect (1990) 1.66
Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol (2004) 1.64
Small-diameter malignant melanoma: a common diagnosis in New South Wales, Australia. J Am Acad Dermatol (1992) 1.64
Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg (1982) 1.62
Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer (2002) 1.58
Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J Surg Oncol (1998) 1.57
Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer (2010) 1.57
Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Arch Dermatol (1996) 1.53
Lymphatic mapping and sentinel node biopsy for melanoma. Expert Rev Anticancer Ther (2001) 1.45
Unusual mycobacteria in 5 cases of opportunistic infections. Pathology (1979) 1.44
The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med (1991) 1.44
Prognostic indicators in centroblastic-centrocytic lymphoma. J Clin Pathol (1988) 1.41
Endocrine influences on survival from malignant melanoma. Cancer (1978) 1.40
Recommendations for the reporting of tissues removed as part of the surgical treatment of cutaneous melanoma. The Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol (1998) 1.40
Prognostic histopathological factors in malignant melanoma. Pathology (1985) 1.39
Developments in surgical oncology--past, present, and future trends. Med J Aust (1992) 1.38
Gallium-67 and technetium-99m-methylene diphosphonate skeletal scintigraphy in determining prognosis for children with stage IV neuroblastoma. J Nucl Med (1993) 1.38
The effects of surgical treatment on survival and local recurrence of cutaneous malignant melanoma. Cancer (1992) 1.38
Immunological effects of solarium exposure. Lancet (1983) 1.38
Uremic cardiomyopathy--effect of hemodialysis on left ventricular function in end-stage renal failure. N Engl J Med (1980) 1.33
Volumetric bone mineral density in normal subjects, aged 5-27 years. J Clin Endocrinol Metab (1996) 1.33
Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern? Head Neck (2001) 1.30
Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg (2000) 1.29
Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971-1998. Aliment Pharmacol Ther (2003) 1.28
Subungual melanoma of the hand. J Hand Surg Am (1996) 1.26
Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg (1991) 1.26
Previous pregnancy as a protective factor against death from melanoma. Lancet (1977) 1.23
Trends in oesophageal and gastric cancer incidence, mortality and survival in England and Wales 1971-1998/1999. Aliment Pharmacol Ther (2003) 1.22
Low natural-killer-cell activity in familial melanoma patients and their relatives. Br J Cancer (1979) 1.22
Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. J Invest Dermatol (1991) 1.22
Thin malignant melanomas and recurrence potential. Arch Surg (1987) 1.21
Naevus cells in lymph nodes. Pathology (1974) 1.20
T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease. Hepatology (1985) 1.20
Parathyroid hormone assay in primary hyperparathyroidism: experiences with a radioimmunoassay based on commercially available reagents. Clin Chem (1974) 1.19
En-bloc resection, extracorporeal irradiation, and re-implantation in limb salvage for bony malignancies. J Bone Joint Surg Br (2005) 1.19
Role of ischemia and infarction in late right ventricular dysfunction after atrial repair of transposition of the great arteries. J Am Coll Cardiol (2000) 1.19
Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I). Br J Surg (1980) 1.18
Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia (1988) 1.18
Predicting survival and recurrence in localized melanoma: a multivariate approach. World J Surg (1992) 1.16
Blood lead concentrations and lead intake in children of different ethnic origin. Hum Toxicol (1985) 1.16
Popliteal lymph node metastasis from primary cutaneous melanoma. Eur J Surg Oncol (2000) 1.16
Late relapse from cutaneous stage I malignant melanoma. Arch Surg (1985) 1.16
Body-composition assessment by dual-energy x-ray absorptiometry in subjects aged 4-26 y. Am J Clin Nutr (1995) 1.15
Facial nerve function after parotidectomy. Arch Otolaryngol Head Neck Surg (1997) 1.15
Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer (1996) 1.15
Risk factors for recurrent urinary tract infection in preschool children. J Paediatr Child Health (1999) 1.14
Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival. Cancer (1980) 1.14
Bone mineral density of total body, spine, and femoral neck in children and young adults: a cross-sectional and longitudinal study. J Bone Miner Res (1994) 1.14
Histologic features of tumors and the female superiority in survival from malignant melanoma. Cancer (1980) 1.14
Non-subungual melanomas of the hand. J Hand Surg Br (1992) 1.13
Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma. J Clin Pathol (2005) 1.13
Lymphatic drainage from the skin of the back to retroperitoneal and paravertebral lymph nodes in melanoma patients. Ann Surg Oncol (1998) 1.12
Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg (2003) 1.12
Patterns of abnormality on bone scans in acute childhood leukemia. J Nucl Med (1998) 1.12
Neck dissection with and without radiotherapy: prognostic factors, patterns of recurrence, and survival. Am J Surg (1986) 1.11
Survival after acute lymphocytic leukaemia: effects of socioeconomic status and geographic region. Arch Dis Child (1999) 1.10
Hyperparathyroidism after renal transplantation. Br Med J (1975) 1.10
Survival from cancer of the pancreas in England and Wales up to 2001. Br J Cancer (2008) 1.10
Relationship between blood lead concentrations and dietary lead intake in infants: the Glasgow Duplicate Diet Study 1979-1980. Food Addit Contam (1986) 1.09
Total thyroidectomy for clinically benign disease of the thyroid gland. Br J Surg (2004) 1.09
Acute ischaemia of the hand resulting from elevation of a radial forearm flap. Br J Plast Surg (1985) 1.09
Survival from cancer of the larynx in England and Wales up to 2001. Br J Cancer (2008) 1.08
Increase in the sensitivity for melanoma diagnosis by primary care physicians using skin surface microscopy. Br J Dermatol (2000) 1.08
Anatomy of Denonvilliers' fascia and pelvic nerves, impotence, and implications for the colorectal surgeon (Br J Surg 2000; 87: 1288-99). Br J Surg (2001) 1.07